Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0GH1I
|
||||
| Former ID |
DNC011096
|
||||
| Drug Name |
3-(4-Hydroxyphenyl)-7-isobutoxychromen-4-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531066] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H18O4
|
||||
| Canonical SMILES |
CC(C)COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O
|
||||
| InChI |
1S/C19H18O4/c1-12(2)10-22-15-7-8-16-18(9-15)23-11-17(19(16)21)13-3-5-14(20)6-4-13/h3-9,11-12,20H,10H2,1-2H3
|
||||
| InChIKey |
WYYSKWHYOXHLTB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Inhibitor | [531066] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.